Eitemau Tebyg: 50 Years of Immunization—Steps Forward
- Why vaccines to HIV, HCV and Malaria have so far failed - Challenges to developing vaccines against immunoregulating pathogens
- mLife
- ImmunoMedicine
- Global Health Research and Policy
- Dynamical Models of Biology and Medicine
- Public Health Challenges
- BMC Medicine
- Integrative Multi-Omics in Biomedical Research
- BMC Public Health
- International Journal of One Health
- Journal of the International AIDS Society
- npj Health Systems
- Health Care Science
- BJPsych International
- Jurnal Ilmiah Kesehatan Sandi Husada
- GeoHealth
- Tobacco Prevention and Cessation
- Health Economics, Policy and Law
- Annals of Global Health
- Global Challenges
- Clinovate: Advances in Medicine and Healthcare
- Health Expectations
- Acta Universitatis Danubius: Administratio
- Gazeta Médica
Pwnc: non-COVID-19 vaccine
- Pwnc: South Kivu
- Pwnc: immunization
- Pwnc: vaccine misinformation
- Pwnc: vaccine reactogenicity
- Pwnc: adverse reactions
- Pwnc: adverse events following immunization
- Pwnc: vaccine injury compensation program
- Pwnc: cholera
- Pwnc: oral cholera vaccine
- Pwnc: vaccination campaign
- Pwnc: cost
- Pwnc: cost-effectiveness
- Pwnc: integration
- Pwnc: vaccination
- Pwnc: service delivery
- Pwnc: systematic review
- Pwnc: maternal and child health
- Pwnc: infant
- Pwnc: HIV
- Pwnc: malaria
- Pwnc: family planning
- Pwnc: poliomyelitis
- Pwnc: epidemiology
- Pwnc: vaccine coverage
- Pwnc: surveillance
- Pwnc: polio eradication
- Pwnc: pertussis
- Pwnc: vaccines
- Pwnc: diagnosis
- Pwnc: vaccine security
- Pwnc: global OPV stockpile
- Pwnc: immunization policy
- Pwnc: inactivated poliovirus vaccine (IPV)
- Pwnc: oral poliovirus vaccine (OPV)
- Pwnc: vaccine production and distribution
- Pwnc: global health security
- Pwnc: poliovirus containment
- Pwnc: vaccine
- Pwnc: microplanning
- Pwnc: microplan
- Pwnc: LMIC
- Pwnc: routine childhood vaccines
- Pwnc: newcomer
- Pwnc: immunizations
- Pwnc: access
- Pwnc: equity
- Pwnc: qualitative methods
- Pwnc: Strategic Advisory Group of Experts (SAGE) on Immunization
- Pwnc: SAGE
- Pwnc: World Health Organization advisory group
- Pwnc: global immunization policy
- Pwnc: immunization strategy
- Pwnc: vaccination policy
- Pwnc: vaccination recommendations
- Pwnc: vaccine hesitancy
- Pwnc: cancer
- Pwnc: pediatric
- Pwnc: immunocompromised
- Pwnc: public health
- Pwnc: influenza
- Pwnc: COVID-19
- Pwnc: respiratory syncytial virus
- Pwnc: outbreaks
- Pwnc: maternal vaccination
- Pwnc: vaccination week in the Americas
- Pwnc: pandemic preparedness and response
- Pwnc: life-course immunization
- Pwnc: coverage increase
- Pwnc: zero-dose
- Pwnc: LMICs
- Pwnc: hepatitis E
- Pwnc: HEV 239
- Pwnc: shorter schedule
- Pwnc: immunogenicity
- Pwnc: efficacy
- Pwnc: zero dose
- Pwnc: under-five vaccination
- Pwnc: human centered design
- Pwnc: advocacy
- Pwnc: community-centric intervention
- Pwnc: National Immunization Technical Advisory Groups
- Pwnc: NITAGs
- Pwnc: WHO–UNICEF Joint Reporting Form
- Pwnc: measles
- Pwnc: under-immunized
- Pwnc: vaccine inequity
- Pwnc: herpes zoster
- Pwnc: varicella zoster virus
- Pwnc: health policy
- Pwnc: Central Africa
- Pwnc: big catch-up
- Pwnc: peer learning
- Pwnc: measles, mumps, and rubella
- Pwnc: MMR
- Pwnc: Denmark
- Pwnc: school
- Pwnc: healthcare
- Pwnc: education
- Pwnc: economic outcomes
- Pwnc: HPV vaccination
- Pwnc: girls
- Pwnc: supplementary immunization activities
- Pwnc: coverage
- Pwnc: disparities
- Pwnc: Togo
- Pwnc: immunization equity
- Pwnc: children with disabilities
- Pwnc: low- and middle-income countries
- Pwnc: vaccine barriers
- Pwnc: vaccination strategies
- Pwnc: inclusive healthcare
- Pwnc: adult
- Pwnc: health workers
- Pwnc: pregnant women
- Pwnc: elderly
- Pwnc: chronic diseases
- Pwnc: Shigella
- Pwnc: children
- Pwnc: phase III study
- Pwnc: endpoints
- Pwnc: safety
- Pwnc: dengue
- Pwnc: Qdenga
- Pwnc: CYD-TDV
- Pwnc: TAK-003
- Pwnc: Wolbachia
- Pwnc: antibody-dependent enhancement
- Pwnc: mRNA vaccines
- Pwnc: school-based programs
- Pwnc: n/a
- Pwnc: thema EDItEUR::M Medicine and Nursing
Pwnc: Vibrio cholerae
- Pwnc: South Kivu
- Pwnc: immunization
- Pwnc: vaccine misinformation
- Pwnc: vaccine reactogenicity
- Pwnc: adverse reactions
- Pwnc: adverse events following immunization
- Pwnc: vaccine injury compensation program
- Pwnc: cholera
- Pwnc: oral cholera vaccine
- Pwnc: vaccination campaign
- Pwnc: cost
- Pwnc: cost-effectiveness
- Pwnc: integration
- Pwnc: vaccination
- Pwnc: service delivery
- Pwnc: systematic review
- Pwnc: maternal and child health
- Pwnc: infant
- Pwnc: HIV
- Pwnc: malaria
- Pwnc: family planning
- Pwnc: poliomyelitis
- Pwnc: epidemiology
- Pwnc: vaccine coverage
- Pwnc: surveillance
- Pwnc: polio eradication
- Pwnc: pertussis
- Pwnc: vaccines
- Pwnc: diagnosis
- Pwnc: vaccine security
- Pwnc: global OPV stockpile
- Pwnc: immunization policy
- Pwnc: inactivated poliovirus vaccine (IPV)
- Pwnc: oral poliovirus vaccine (OPV)
- Pwnc: vaccine production and distribution
- Pwnc: global health security
- Pwnc: poliovirus containment
- Pwnc: vaccine
- Pwnc: microplanning
- Pwnc: microplan
- Pwnc: LMIC
- Pwnc: routine childhood vaccines
- Pwnc: newcomer
- Pwnc: immunizations
- Pwnc: access
- Pwnc: equity
- Pwnc: qualitative methods
- Pwnc: Strategic Advisory Group of Experts (SAGE) on Immunization
- Pwnc: SAGE
- Pwnc: World Health Organization advisory group
- Pwnc: global immunization policy
- Pwnc: immunization strategy
- Pwnc: vaccination policy
- Pwnc: vaccination recommendations
- Pwnc: vaccine hesitancy
- Pwnc: cancer
- Pwnc: pediatric
- Pwnc: immunocompromised
- Pwnc: public health
- Pwnc: influenza
- Pwnc: COVID-19
- Pwnc: respiratory syncytial virus
- Pwnc: outbreaks
- Pwnc: maternal vaccination
- Pwnc: vaccination week in the Americas
- Pwnc: pandemic preparedness and response
- Pwnc: life-course immunization
- Pwnc: coverage increase
- Pwnc: zero-dose
- Pwnc: LMICs
- Pwnc: hepatitis E
- Pwnc: HEV 239
- Pwnc: shorter schedule
- Pwnc: immunogenicity
- Pwnc: efficacy
- Pwnc: zero dose
- Pwnc: under-five vaccination
- Pwnc: human centered design
- Pwnc: advocacy
- Pwnc: community-centric intervention
- Pwnc: National Immunization Technical Advisory Groups
- Pwnc: NITAGs
- Pwnc: WHO–UNICEF Joint Reporting Form
- Pwnc: measles
- Pwnc: under-immunized
- Pwnc: vaccine inequity
- Pwnc: herpes zoster
- Pwnc: varicella zoster virus
- Pwnc: health policy
- Pwnc: Central Africa
- Pwnc: big catch-up
- Pwnc: peer learning
- Pwnc: measles, mumps, and rubella
- Pwnc: MMR
- Pwnc: Denmark
- Pwnc: school
- Pwnc: healthcare
- Pwnc: education
- Pwnc: economic outcomes
- Pwnc: HPV vaccination
- Pwnc: girls
- Pwnc: supplementary immunization activities
- Pwnc: coverage
- Pwnc: disparities
- Pwnc: Togo
- Pwnc: immunization equity
- Pwnc: children with disabilities
- Pwnc: low- and middle-income countries
- Pwnc: vaccine barriers
- Pwnc: vaccination strategies
- Pwnc: inclusive healthcare
- Pwnc: adult
- Pwnc: health workers
- Pwnc: pregnant women
- Pwnc: elderly
- Pwnc: chronic diseases
- Pwnc: Shigella
- Pwnc: children
- Pwnc: phase III study
- Pwnc: endpoints
- Pwnc: safety
- Pwnc: dengue
- Pwnc: Qdenga
- Pwnc: CYD-TDV
- Pwnc: TAK-003
- Pwnc: Wolbachia
- Pwnc: antibody-dependent enhancement
- Pwnc: mRNA vaccines
- Pwnc: school-based programs
- Pwnc: n/a
- Pwnc: thema EDItEUR::M Medicine and Nursing